The enzyme PI3K plays a critical role in cell migration. Scientists have long understood this function. But researchers have recently unveiled that a subunit of this enzyme also has the ability to ...

Evexomostat combination shows clinical benefit and favorable safety in heavily pretreated HR+/HER2− mBC patients with ...

Joenja® (leniolisib) is first approved treatment in the European Union for activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS), a ...

DelveInsight’s 'PI3K Inhibitors Pipeline Insight 2024' report provides comprehensive global coverage of pipeline PI3K inhibitors in various stages of clinical development, major pharmaceutical ...

MEKanistic Therapeutics, a biotechnology company developing first-in-class precision medicines designed to overcome cancer resistance mechanisms, today announced that the U.S. Food and Drug ...

Although significant progress has been made in the treatment and management of patients with FL, several challenges remain, including the need to develop better prognostic models and markers for ...

PI3 kinases are obvious targets for researchers developing cancer drugs. Formally known as phosphatidylinositol-3 kinases, the enzymes are involved in a laundry list of functions that contribute to ...

Please provide your email address to receive an email when new articles are posted on . The FDA Oncologic Drugs Advisory Committee voted Thursday in favor of randomized data to support future ...

The PI3K/Akt/mTOR pathway has a central role in cancer metastasis and radiotherapy. To develop effective therapeutics to improve radiosensitivity, understanding the possible pathways of ...

Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. The current PI3K 3C inhibitors in use in ...